Grantham, Mayo, Van Otterloo & Co (GMO)’s Vicor VICR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,600
Closed -$249K 832
2020
Q1
$249K Buy
+5,600
New +$266K ﹤0.01% 682

Other funds holding VICR

Grantham, Mayo, Van Otterloo & Co (GMO)'s VICR Position: Q2 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Vicor (VICR) in Q2 2020, closing a stake of 5,600 shares — an estimated $249K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in VICR in Q1 2020 and held it in 1 quarter. The position peaked at $249K in Q1 2020. 184 funds tracked by Wall St. Rank hold VICR as of Q2 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Vicor position as of Q2 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 5,600 Vicor shares in Q2 2020, an estimated $249K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Vicor in Q1 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Vicor position peaked at $249K in Q1 2020.
  • 184 funds tracked by Wall St. Rank held Vicor as of Q2 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2020, filed 13 Aug 2020.